Alexza Pharmaceuticals shares are tanking in early trading after the company announced today that the U.S. Food and Drug Administration has not approved its AZ-004, an antipsychotic inhaled drug for treating agitation in schizo…
Jazz Pharmaceuticals shares slumped more than 5% in premarket trading Monday after the company announced that the FDA had denied approval for its fibromyalgia treatment, sodium oxybate. While approved to treat narcolepsy, sodi…
AstraZeneca and Pozen announced Monday that their pain reliever Vimovo for the treatment of arthritis had received positive agreement for approval by the 23 E.U. nations. Vimovo is a combination drug that reduces the risk of ul…
Traditional chemotherapy for cancer patients is as dreaded as the disease itself. But Delcath’s “Chemosaturation System,” which is doing well so far in tests, promises to deliver treatments far more precisely, thus limiting sid…
IBISWorld Research has uncovered five industries that managed to stay extremely profitable during 2010 — and these industries are their picks to be the most profitable for the next three years. Investors could boost their port…